BMY

Bristol-Myers Squibb Company

Ten-year history of valuation, safety, growth and profitability, with percentile bands against BMY’s own range.

Snapshot

P/E

8.9×

P51

Yield

4.3%

P76

FCF payout

44.5%

P40

Net debt / EBITDA

6.96

P41

DGR 5y

5.9%

ROIC

4.7%

P94

Value

Is the share cheap or dear by its own history?

BMY is mid-band on valuation. P/E at P51 (8.9x); yield at P76 (4.3%).

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P40 (45%) of its history. Leverage (Net Debt/EBITDA) at P41 (6.96); interest cover at P21 (10.04).

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at P0 (6%) of its 10y range. FCF growth P4 (-22%); ROIC P94 (5%).

Profitability

Is the engine getting better or worse at making money?

Gross margin at P88 (70%) of its history. Operating margin P93 (28%); net margin P85 (19%).

Forecast your income with the BMY dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.